Cargando…
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
PURPOSE: Definitive antiviral treatment is not available for COVID-19 infection, with the exception of remdesivir, which still evokes many doubts. Various monotherapy or combination therapies with antivirals or other agents have been tried. The present study aims to evaluate the therapeutic potentia...
Autores principales: | Panda, Prasan Kumar, Singh, Budha O, Moirangthem, Bikram, Bahurupi, Yogesh Arvind, Saha, Sarama, Saini, Girraj, Dhar, Minakshi, Bairwa, Mukesh, Pai, Venkatesh Srinivasa, Agarwal, Ankit, Sindhwani, Girish, Handu, Shailendra, Kant, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487855/ https://www.ncbi.nlm.nih.gov/pubmed/34616188 http://dx.doi.org/10.2147/CPAA.S325083 |
Ejemplares similares
-
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
por: Panda, Prasan Kumar, et al.
Publicado: (2020) -
Clinical Characteristics of 100 Patients With COVID-19-Associated Mucormycosis From a Tertiary Care Center in North India
por: Kant, Ravi, et al.
Publicado: (2022) -
Pentraxin 3 (PTX3) as a Predictor of Severity of Sepsis in Patients Admitted to an Intensive Care Unit: A Cross-Sectional Study From North India
por: Ronanki, Kavya, et al.
Publicado: (2022) -
Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis
por: Kapoor, Mayank, et al.
Publicado: (2021) -
Awareness, perception, and mitigating measures on COVID-19: Do we still need to educate our masses on COVID-19?
por: Bairwa, Mukesh, et al.
Publicado: (2021)